APOE genetics is clinically useful for assessing risk of Alzheimer's disease (ε4 allele) and cardiovascular disease (ε2/ε4). However, its practical utility is limited: a positive ε4 result increases risk but is not diagnostic; many carriers never develop the disease, and no proven prevention exists based solely on genotype. In nutrigenetics, APOE is sometimes used to tailor dietary fat intake, but evidence for personalized recommendations is moderate. Direct-to-consumer tests often include APOE, but without medical guidance the result can cause anxiety. The test is most valuable when there is a family history of early-onset Alzheimer's or unexplained lipid disorders. Current guidelines do not recommend population screening. In summary, APOE genetics is useful as a risk marker in specific clinical contexts, not as a general wellness tool.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-76ea0a34c0cf67573d0ece6b